Consensus Ocular Therapeutix, Inc.

Equities

OCUL

US67576A1007

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-10 EDT			5-day change	1st Jan Change
5.66 ^USD	-3.08%		-8.27%	+26.91%

05-07	Earnings Flash (OCUL) OCULAR THERAPEUTIX Posts Q1 Revenue $14.8M, vs. Street Est of $15.4M	MT
05-07	Ocular Therapeutix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Ocular Therapeutix, Inc.

Price target over the last 5 years

History of analyst recommendation changes

b87eefe2334d60d73.EMg-lrofkkdyLD96zSCkl6lZeS-CZY3gchz3cLrvgpk.I756w-8q3wMWHAcPgGvS0P5hTGPtAcO5RiS4NvWg0uhZoEn3i1LFCgUZBw~289e2b8e98fa99a5b57e0f141b67f6fa

Analyst Recommendations on Ocular Therapeutix, Inc.

HC Wainwright Adjusts Price Target on Ocular Therapeutix to $15 From $12, Keeps Buy Rating	03-13	MT
TD Cowen Adjusts Price Target on Ocular Therapeutix to $11 From $8, Maintains Market Perform Rating	03-12	MT
JMP Securities Adjusts Ocular Therapeutix's Price Target to $24 From $12, Maintains Market Outperform Rating	03-12	MT
Piper Sandler Adjusts Ocular Therapeutix Price Target to $15 From $10, Maintains Overweight Rating	02-26	MT
HC Wainwright Adjusts Ocular Therapeutix Price Target to $12 From $10, Maintains Buy Rating	23-06-13	MT
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $10 From $11, Maintains Buy Rating	23-05-09	MT
JMP Securities Adjusts Price Target on Ocular Therapeutix to $12 From $11, Keeps Market Outperform Rating	23-05-09	MT
Baird Initiates Ocular Therapeutix at Outperform With $18 Price Target	23-04-21	MT
JMP Securities Adjusts Price Target on Ocular Therapeutix to $11 From $12, Maintains Market Outperform Rating	23-03-07	MT
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $11 From $9, Maintains Buy Rating	23-02-14	MT
JMP Securities Adjusts Price Target on Ocular Therapeutix's to $12 From $25, Maintains Market Outperform Rating	23-01-09	MT
Raymond James Adjusts Price Target on Ocular Therapeutix to $14 From $29, Maintains Strong Buy Rating	22-11-08	MT
HC Wainwright Trims Price Target on Ocular Therapeutix to $9 From $10, Maintains Buy Rating	22-11-08	MT
Berenberg Bank Assumes Coverage on Ocular Therapeutix With Buy Rating, $15 Price Target	22-08-10	MT
JMP Securities Adjusts Ocular Therapeutix Price Target to $25 From $20, Maintains Market Outperform Rating	22-08-09	MT
Jefferies Raises Price Target for Ocular Therapeutix to $6.50 From $5, Maintains Buy Rating	22-08-09	MT
Berenberg Bank Suspends Coverage of 25 Companies in Consumer Discretionary, Healthcare, Industrial Tech, and Software Sectors	22-07-01	MT
Piper Sandler Adjusts Price Target on Ocular Therapeutix to $10 From $16, Reiterates Overweight Rating	22-05-31	MT
Berenberg Bank Cuts Price Target on Ocular Therapeutix to $21 From $23, Maintains Buy Rating	22-05-11	MT
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $10 From $14, Reiterates Buy Rating	22-05-10	MT
Piper Sandler Adjusts Price Target on Ocular Therapeutix to $16 From $20, Reiterates Overweight Rating	22-05-10	MT
JMP Securities Adjusts Ocular Therapeutix's Price Target to $22 from $30, Keeps Market Outperform Rating	22-03-01	MT
Berenberg Bank Adjusts Price Target on Ocular Therapeutix to $23 From $26, Maintains Buy Rating	21-11-10	MT
JMP Securities Adjusts Price Target on Ocular Therapeutix to $30 From $27, Maintains Market Outperform Rating	21-11-09	MT
OCULAR THERAPEUTIX : Piper Sandler Adjusts Price Target on Ocular Therapeutix to $20 From $27, Maintains Overweight Rating	21-10-25	MT